Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
|
17529973 |
2007 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
|
17529973 |
2007 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
We genotyped 13 single nucleotide polymorphisms (SNPs) densely covering a 27 kb region within intron 2 of FGFR2 including two SNPs (rs2981582 and rs1219648) significantly associated with breast cancer and a total 40 tagSNPs across 150 kb of the FGFR2 gene.
|
18285324 |
2008 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
We genotyped 13 single nucleotide polymorphisms (SNPs) densely covering a 27 kb region within intron 2 of FGFR2 including two SNPs (rs2981582 and rs1219648) significantly associated with breast cancer and a total 40 tagSNPs across 150 kb of the FGFR2 gene.
|
18285324 |
2008 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Genetic variation in FGFR2, identified by rs1219648, may account for a substantial fraction of breast cancer in Arab (12%), Ashkenazi (15%), and Sephardi Jewish (22%) populations.
|
18483326 |
2008 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
Genetic variation in FGFR2, identified by rs1219648, may account for a substantial fraction of breast cancer in Arab (12%), Ashkenazi (15%), and Sephardi Jewish (22%) populations.
|
18483326 |
2008 |
Endometrial Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
We also observed a nonsignificant inverse association with rs889312 (MAP3K1) variant carriers [OR = 0.85 (95% CI: 0.68-1.05)] and rs1219648 (FGFR2) variant carriers [OR= 0.86 (95% CI: 0.69-1.06) and endometrial cancer risk.
|
18785201 |
2008 |
Malignant neoplasm of endometrium
|
|
0.010 |
GeneticVariation
|
BEFREE |
We also observed a nonsignificant inverse association with rs889312 (MAP3K1) variant carriers [OR = 0.85 (95% CI: 0.68-1.05)] and rs1219648 (FGFR2) variant carriers [OR= 0.86 (95% CI: 0.69-1.06) and endometrial cancer risk.
|
18785201 |
2008 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
FGFR2 rs1219648 and rs2981582 genotypes were significantly associated with breast cancer</span> in EA only in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and HER2/Neu-negative (HER2-) tumors.
|
19028704 |
2009 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
FGFR2 rs1219648 and rs2981582 genotypes were significantly associated with breast cancer</span> in EA only in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and HER2/Neu-negative (HER2-) tumors.
|
19028704 |
2009 |
Neoplasms
|
|
0.020 |
GeneticVariation
|
BEFREE |
FGFR2 rs1219648 and rs2981582 genotypes were significantly associated with breast cancer in EA only in estrogen receptor-positive (ER+), progesterone receptor-positive (PR+) and HER2/Neu-negative (HER2-) tumors.
|
19028704 |
2009 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Two single-nucleotide polymorphisms, rs13387042 (2q35) and rs1219648 (FGFR2 gene), were found to be associated with breast cancer risk.
|
19789366 |
2009 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
Two single-nucleotide polymorphisms, rs13387042 (2q35) and rs1219648 (FGFR2 gene), were found to be associated with breast cancer risk.
|
19789366 |
2009 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Three commonly studied FGFR2 polymorphisms including rs1219648 (A > G), rs2420946 (C > T), and rs2981582 (C > T) were selected to explore their association with risk of development of breast cancer by meta-analysis of published case-control studies.
|
20300826 |
2010 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
Three commonly studied FGFR2 polymorphisms including rs1219648 (A > G), rs2420946 (C > T), and rs2981582 (C > T) were selected to explore their association with risk of development of breast cancer by meta-analysis of published case-control studies.
|
20300826 |
2010 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
In conclusion, this meta-analysis suggests that rs2981582, rs1219648, and rs2420946 polymorphisms in FGFR2 are associated with elevated BC risk.
|
20364400 |
2010 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
In conclusion, this meta-analysis suggests that rs2981582, rs1219648, and rs2420946 polymorphisms in FGFR2 are associated with elevated BC risk.
|
20364400 |
2010 |
Nasopharyngeal carcinoma
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.
|
20512145 |
2010 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
In this study, we evaluated the association of the SNP rs1982073 (Leu10Pro) in transforming growth factor-beta 1 (TGFB1) gene and the SNP rs1219648 in fibroblast growth factor receptor 2 (FGFR2) gene with the risk and aggressiveness of breast cancer among women of Han nationality in North China.
|
20640597 |
2011 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
Therefore, the SNPs of TGFB1 rs1982073 and FGFR2 rs1219648 may contribute to the identification of patients with more aggressive breast cancers among Han women in North China.
|
20640597 |
2011 |
Secondary malignant neoplasm of lymph node
|
|
0.010 |
GeneticVariation
|
BEFREE |
For FGFR2 SNP rs1219648, G-carriers (A/G+G/G genotype) were more significantly linked to tumors with lymph node metastasis than those with A/A genotype (lymph node negative) (OR = 1.69, 95% CI: 1.11-2.58, P = 0.016).
|
20640597 |
2011 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
BEFREE |
The FGFR2-breast cancer association was modified by smoking status, with increased risk for former and current smokers compared to never smokers; former/current smokers carrying two copies of the rs1219648 minor allele were at highest risk with a crude OR (95% confidence interval) of 2.11 (1.52-2.92) compared to never smokers with no rs1219648 variant alleles.
|
20853316 |
2011 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
BEFREE |
The FGFR2-breast cancer association was modified by smoking status, with increased risk for former and current smokers compared to never smokers; former/current smokers carrying two copies of the rs1219648 minor allele were at highest risk with a crude OR (95% confidence interval) of 2.11 (1.52-2.92) compared to never smokers with no rs1219648 variant alleles.
|
20853316 |
2011 |
Breast Carcinoma
|
|
0.800 |
GeneticVariation
|
GWASCAT |
A combined analysis of genome-wide association studies in breast cancer.
|
20872241 |
2011 |
Malignant neoplasm of breast
|
|
0.800 |
GeneticVariation
|
GWASDB |
A combined analysis of genome-wide association studies in breast cancer.
|
20872241 |
2011 |